CTNNB1 and liver cancer: According to the whole genome sequencing analysis using liver cancer samples, intrinsic immunosuppression, a major barrier to the enhancement of immunotherapy, is driven by the mutually exclusive mechanisms of tumor-associated macrophages, Tregs, CTNNB1 mutation, and cytolytic activity49.